YE Z L, DING Y M, CHEN Z, LI Z, MA S, XU Z H, CHENG L, WANG X Y, ZHANG X X, DING N, ZHANG Q, QIAN Q J. Detecting and phenotyping of aneuploidcirculating tumor cells in patients with various malignancies [J]. Cancer Biol Ther, 2019, 20(4): 546-51.

Zhu, L N, WU R J,YE Z L, et al. "Identification of two novel TPK1 gene mutations in a Chinese patient with thiamine pyrophosphokinase deficiency undergoing wholeexome sequencing" Journal of Pediatric Endocrinology and Metabolism, 32.3 (2019): 295-300. Retrieved 13 Jun. 2019, from doi:10.1515/jpem-2018-0363

YE Z L, QIAN Q M, JIN H J, QIAN Q J. Cancer vaccine: learning lessons from immune checkpoint inhibitors [J]. J Cancer, 2018, 9(2): 263-8.

LV S Q, YE Z L, LIU P Y, HUANG Y, LI L F, LIU H, ZHU H L, JIN H J, QIAN Q J. 11R-P53 and GM-CSF Expressing Oncolytic Adenovirus Target Cancer Stem Cellswith Enhanced Synergistic Activity [J]. J Cancer, 2017, 8(2): 199-206.

XU J Y, YE Z L, JIANG D Q, HE J C, DING Y M, LI L F, LV S Q, WANG Y, JIN H J, QIAN Q J. Mesothelin-targeting chimeric antigen receptor-modified T cells bypiggyBac transposon system suppress the growth of bile duct carcinoma [J]. Tumor Biol, 2017, 39(4): 11.

Jinrong Qiu, Fuping Zhou, Xinchun Li,Sufang Zhang,Zhuo Chen,Zenghui Xu,Gaoxiong Lu,Zhi Zhu,Na Ding,Jinxing Lou,Zhenglong Ye,Qijun Qian, Changes and Clinical Significance of Detailed Peripheral Lymphocyte Subsets in Evaluating the Immunity for Cancer Patients [J]Cancer Management and Research,2020:12 209–219

Xinchun Li, You li, Wenqi Shao, Zhong Li, Ren Zhao, Zhenlong Ye,Strategies for enrichment of circulating tumor cells. [J]Transl Cancer Res, 2020;9(3):2012-2025.

Shuo Ma1,Xinchun Li, Xinyue Wang, Liang Cheng, Zhong Li, Changzheng Zhang, Zhenlong Ye, Qijun Qian, Current Progress in CAR-T Cell Therapy for Solid Tumors[J]International Journal of Biological Sciernces, 2019;15(12):2548-2560.

Zhenlong Ye, Yongmei Ding, Zhuo Chen, Zhong Li, Shuo Ma, Zenghui Xu, Liang Chen, Xinyue Wang, Xiaoxia Zhang, Na Ding, Qian Zhang&Qijun Qian, Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.[J]Cancer Biology&Therapy,2019,VOL,20,NO.4,546-551.

Lina Zhu, Ruijuan Wu, Zhenlong Ye,Ruijie Gu,Yongxia Wang, Yu hou, Zhichun Feng and Xinwei Ma. Identification of two novel TPK1 gene mutations in a Chinese patient with thiamine pyrophosphokinase deficiency undergoing whole exome sequencing.[J]J Pediatr Endocrinol Metab 2019; 32(3): 295–300.

Yuan Zhuang, Changzheng Zhang, Qiong Wu, Jing Zhang, Zhenlong Ye. Application of immune reportoire sequencing in cancer immunotherapy.[J]International Immunopharmacology, 74(2019)105688.

李忠，孙艳，钱其军. 精准靶向肿瘤局部的免疫治疗有可能成为治愈癌症的关键性策略[J]中国肿瘤生物治疗杂志，2019，Vol. 26,No.1

Zhenlong Ye, Yongmei Ding, Zhuo Chen, Zhong Li, Shuo Ma, Zenghui Xu, Liang Chen, Xinyue Wang, Xiaoxia Zhang, Na Ding, Qian Zhang&Qijun Qian. CTC Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.[J]Cancer Biology&Therapy,

ZhenLong Ye, Qiming Qian, HuaJun Jin, QiJun Qian. Cancer vaccine learning lessons from immune checkpoint inhibitors[J]Journal of Cancer 2018,vol.9

Jie-Ying Xu, Zhen-Long Ye, Du-Qing Jiang, Jiang-Chuan He, Yong-Mei Ding, Lin-Fang Li, Sai-Qun Lv, Ying Wang, Hua-Jun Jin and Qi-Jun Qian. Mesothelin-targeting chimeric antigen receptor–modified T cells by piggyBac transposon system suppress the growth of bile duct carcinoma[J]Tumor Biology,April 2017: 1 –11

Sai-qun Lv, Zhen-long Ye, Pin-yi Liu, Yao Huang, Lin-fang Li, Hui Liu, Hai-li Zhu, Hua-jun Jin, Qi-jun Qian. 11R-P53 and GM-CSF Expressing Oncolytic Adenovirus Target Cancer Stem Cells with Enhanced Synergistic Activity[J]Journal of Cancer, 2017,vol.8

Hao Zhang, Zhen-long Ye, Zhen-gang Yuan, Zheng-qiang Luo, Hua-jun Jin, Qi-jun qian. New Strategies for the Treatment of Solid Tumors with CAR-T Cells[J]International Journal of Biological Sciences. 2016; 12(6): 718-729.

Zhen-long YE, Yao HUANG, Lin-fang LI, Hai-li ZHU, Hai-xia GAO, Hui LIU, Sai-qun LV, Zeng-hui XU, Luo-ning ZHENG,Tao LIU, Jing-lei ZHANG, Hua-jun JIN, Qi-jun QIAN. Argonaute 2 promotes angiogenesis via the PTEN VEGF signaling pathway in human hepatocellular carcinoma[J]Acta Pharmacologica Sinica 2015: 1–9

ZhenLong Ye, HuaJun Jin, QiJun Qian. Argonaute 2 A Novel Rising Star in Cancer Research[J]Journal of Cancer.2015; 6(9): 877-882.